These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 193662)

  • 1. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
    Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
    Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients.
    Lamelin JP; de-The G; Revillard JP; Gabbiani G
    IARC Sci Publ (1971); 1978; (20):523-36. PubMed ID: 215532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W; Henle G
    Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
    [No Abstract]   [Full Text] [Related]  

  • 4. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.
    Joncas JH; Rioux E; Wastiaux JP; Leyritz M; Robillard L; Menezes J
    Can Med Assoc J; 1976 Nov; 115(9):858-60. PubMed ID: 186168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
    Gunven P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in three populations of Burkitt's lymphoma patients.
    Vainio E; Lenoir GM; Franklin RM
    Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
    Rowe M; Finke J; Szigeti R; Klein G
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
    Jondal M; Gunven P
    Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic markers for Epstein-Barr virus in the control of nasopharyngeal carcinoma and Burkitt lymphoma.
    Levine PH
    Cancer Detect Prev Suppl; 1987; 1():217-23. PubMed ID: 2826001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P
    Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies.
    Henle W; Henle G
    Laryngoscope; 1977 Apr; 87(4 Pt 1):467-73. PubMed ID: 190497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology and nature of the association between herpesviruses (EBV and herpes simplex) and several human tumors. Recent results].
    de-Thé G
    Bull Cancer; 1976; 63(3):417-26. PubMed ID: 187271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma.
    Inoue M; Klein G
    Clin Exp Immunol; 1970 Jul; 7(1):39-50. PubMed ID: 4320551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma.
    Klein G
    Isr J Med Sci; 1977 Jul; 13(7):716-24. PubMed ID: 200586
    [No Abstract]   [Full Text] [Related]  

  • 18. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.
    Geser A; Brubaker G; Olwit GW
    Rev Epidemiol Sante Publique; 1980 Oct; 28(3):307-21. PubMed ID: 6258200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
    Morrow RH; Sever JL; Henderson BE
    Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
    [No Abstract]   [Full Text] [Related]  

  • 20. Malaria antibody levels in patients with nasopharyngeal carcinoma.
    Yadav M; Prasad U
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.